Drugs / Cocaine
Cocaine
Drug Schedule II controlled substance; available in the U.S. as a prescription medical product.Local anesthetic; stimulant; SNDRI
- Registered trials
- 22
- Ongoing
- 0/ 0%
- Completed
- 19
- Indications
- 1
Approved indications
| Indication |
|---|
| Topical local anesthesia in selected medical contexts |
Clinical trial landscape
22 registered studies reference this molecule or one of its brands. The split below shows how many are ongoing versus completed per phase.
| Phase | Total | Ongoing | Completed | Split |
|---|---|---|---|---|
| Early Phase 1 | 8 | 0 | 7 | |
| Phase 1 | 7 | 0 | 7 | |
| Phase 4 | 2 | 0 | 1 | |
| Phase 2 | 2 | 0 | 1 | |
| Not applicable | 2 | 0 | 2 | |
| Phase 1/2 | 1 | 0 | 1 | |
| All phases | 22 | 0 | 19 |
Ongoing Completed Balance withdrawn, terminated, or status unreported.
Study records: ClinicalTrials.gov →
Mechanism of action
Monoamine reuptake inhibition profile (SNDRI) with local anesthetic action.
Recent developments
Headlines link to the original publisher. Sources limited to a reviewed list of journals, regulators, and medical press.